Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fermented Grape Combined With Fruits and Vegetables Drink on Anti-aging and Anti-inflammatory

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04805697
Recruitment Status : Completed
First Posted : March 18, 2021
Last Update Posted : March 22, 2021
Sponsor:
Information provided by (Responsible Party):
TCI Co., Ltd.

Brief Summary:
60 subjects were recruited and divided into placebo group and fermented grape drinks group.

Condition or disease Intervention/treatment Phase
Skin Condition Dietary Supplement: placebo group Dietary Supplement: fermented grape drinks Not Applicable

Detailed Description:
In this study, using a fermented grape drinks made of fermented grapes with fruit and vegetable powder to explore whether it can improve the skin's condition and achieve anti-inflammatory effects. Sixty subjects were recruited and divided into placebo group and fermented grape drinks group. After drinking for 8 weeks, skin test and blood biochemical analysis were performed.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Fermented Grape Drinks Made of Fermented Grapes With Fruit and Vegetable Powder to Explore Whether it Can Improve the Skin's Condition and Achieve Anti-inflammatory Effects.
Actual Study Start Date : October 1, 2019
Actual Primary Completion Date : August 31, 2020
Actual Study Completion Date : October 31, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Skin Conditions

Arm Intervention/treatment
Placebo Comparator: placebo group
subjects drank 50 ml , 1 bottle a day for 8 week
Dietary Supplement: placebo group
subjects drank 50 ml , 1 bottle a day for 8 week

Experimental: fermented grape drinks
subjects drank 50 ml , 1 bottle a day for 8 week
Dietary Supplement: fermented grape drinks
subjects drank 50 ml , 1 bottle a day for 8 week




Primary Outcome Measures :
  1. skin brightness [ Time Frame: 8 week ]
    The subjects divided into a placebo group (n=30) and an experimental group (n=30). Each subject was informed to consume one bottle of a 50 mL of grape drink or a placebo drink daily for 8 weeks, then using corneometer CM825 to examine skin brightness (The higher the value, the more water content, C.U., corneometer units )

  2. skin elasticity [ Time Frame: 8 week ]
    The subjects divided into a placebo group (n=30) and an experimental group (n=30). Each subject was informed to consume one bottle of a 50 mL of grape drink or a placebo drink daily for 8 weeks, then using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)

  3. skin moisture [ Time Frame: 8 week ]
    The subjects divided into a placebo group (n=30) and an experimental group (n=30). Each subject was informed to consume one bottle of a 50 mL of grape drink or a placebo drink daily for 8 weeks, then using probe system GL2000 & MPA10 to examine skin moisture (The higher the value, the higher the gloss, no unit)

  4. skin spot [ Time Frame: 8 week ]
    The subjects divided into a placebo group (n=30) and an experimental group (n=30). Each subject was informed to consume one bottle of a 50 mL of grape drink or a placebo drink daily for 8 weeks, then usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)

  5. skin wrinkle [ Time Frame: 8 week ]
    The subjects divided into a placebo group (n=30) and an experimental group (n=30). Each subject was informed to consume one bottle of a 50 mL of grape drink or a placebo drink daily for 8 weeks, then using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)

  6. inflammatory cytokines [ Time Frame: 8 week ]
    The subjects divided into a placebo group (n=30) and an experimental group (n=30). Each subject was informed to consume one bottle of a 50 mL of grape drink or a placebo drink daily for 8 weeks, then using ELISA kit to examine inflammatory cytokines (pg/ml)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Dry skin.
  2. Rough skin
  3. Large pores
  4. Dark yellow complexion
  5. Sagging skin

Exclusion Criteria:

  1. Skin disorders
  2. Liver diseases
  3. Kidney diseases
  4. Allergy to cosmetics, drugs, or foods
  5. Pregnant and lactating women
  6. People who had any cosmetic procedures before 4 weeks of the study
  7. Area of facial spot over 3 cm2
  8. Vegan
  9. People who took collagen supplements in the past 3 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04805697


Locations
Layout table for location information
Taiwan
Research & Design Center, TCI CO., Ltd
Taipei, Taiwan, 100225
Sponsors and Collaborators
TCI Co., Ltd.
Investigators
Layout table for investigator information
Study Director: Chia-Hua Liang, Ph.D Chia Nan University of Pharmacy & Science
Layout table for additonal information
Responsible Party: TCI Co., Ltd.
ClinicalTrials.gov Identifier: NCT04805697    
Other Study ID Numbers: 20-054-B
First Posted: March 18, 2021    Key Record Dates
Last Update Posted: March 22, 2021
Last Verified: March 2021

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Skin Diseases
Disease
Pathologic Processes